HC Wainwright & Co. Upgrades Bionomics to Buy, Announces $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis has upgraded Bionomics (NASDAQ:BNOX) from Neutral to Buy and announced a price target of $8.
September 28, 2023 | 4:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bionomics has been upgraded from Neutral to Buy by HC Wainwright & Co. with a new price target of $8.
The upgrade from Neutral to Buy by HC Wainwright & Co. indicates a positive outlook for Bionomics. The new price target of $8 suggests potential upside for the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100